bioMérieux to Showcase Nutraceutical Testing Solutions

10.16.21

Recently Released NUTRAPLEX PRO Assay simultaneously detects E. coli, S. aureus, and Salmonella spp. from a single universal enrichment in 24 hours.

bioMérieux, a leader in the field of in vitro diagnostics, will exhibit at SupplySide West Booth 6634, including its newly released GENE-UP NUTRAPLEX PRO Assay, which was recently awarded the first-ever AOAC Research Institute Performance Tested Methods approval (PTM 082103) for multiplex USP pathogen detection and PCR-based culture confirmation in nutraceutical products. With this certification, GENE-UP NUTRAPLEX PRO outperformed both FDA BAM and USP <2022>. 
 
“We look forward to engaging with existing and new customers at SupplySide West and showcasing our innovative nutraceutical testing solutions,” said Ben Pascal, chief business officer with Invisible Sentinel, a bioMérieux company. “There is an industry notion that rapid testing is not an acceptable equivalent to USP methods, and we’d like to show the industry how bioMérieux has revolutionized rapid testing methods, paving the way for the future of testing for nutraceuticals.”
  
The GENE-UP NUTRAPLEX PRO is a multiplex assay that simultaneously detects Escherichia coli, Salmonella spp. and Staphylococcus aureus from a single universal enrichment in 24 hours. GENE-UP NUTRAPLEX PRO meets the needs of USP <2022> across a wide variety of challenging nutraceutical matrices, while improving overall efficiencies.
 
As an innovator in nutraceuticals testing, bioMérieux helps customers go from complex testing methods to simple rapid methods through its full suite of testing solutions, including the GENE-UP NUTRAPLEX PRO. Other solutions include the automated enumeration TEMPO system and immunoassay pathogen screening VIDAS system, among others that can bring both precision and speed in testing functional foods and beverages as well as dietary, herbal and protein supplements and vitamins.
 
While the size of the U.S. nutraceuticals market is projected to reach around $120 million by the end of 2027, bioMérieux is revolutionizing previous testing methods and outperforms traditional USP culture methods. This is a paradigm shift in microbial quality testing for nutraceuticals. There is a faster, alternative testing method allowed by USP methodology, the industry standard for nutraceutical microbiology safety and quality testing. Traditional culture-based methods and available singleplex molecular assays are cost and labor prohibitive with less accuracy across the diverse range of nutraceutical matrices. Previous and widely accepted methods of testing nutraceuticals are now being met with an entirely new way to test via bioMérieux’s breakthrough technology and rapid testing.
 
SupplySide West attendees will have an opportunity to meet firsthand with bioMérieux’s team of experts who can help advise and provide education on the next generation of testing solutions for those looking to simplify, streamline and bring greater efficiency to nutraceuticals testing.